Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection
NCT04372017
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Unlikelihood of benefit based on other studies.
Conditions
COVID-19
SARS-CoV 2
Interventions
DRUG:
Hydroxychloroquine
DIETARY_SUPPLEMENT:
Vitamin D
Sponsor
Sanford Health